Literature DB >> 24633573

Membranoproliferative glomerulonephritis, type II cryoglobulinemia and triple therapy for hepatitis C: a case series and review of the literature.

Kevin Humphries1, Jama M Darling, A Sidney Barritt.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2014        PMID： 24633573     DOI： 10.1007/s10620-014-3085-7

Source DB:  PubMed          Journal:  Dig Dis Sci        ISSN： 0163-2116            Impact factor:   3.487


× No keyword cloud information.
  27 in total

1.  Interferon-alpha and ribavirin treatment in patients with hepatitis C virus-related systemic vasculitis.

Authors:  Patrice Cacoub; Olivier Lidove; Thierry Maisonobe; Pierre Duhaut; Vincent Thibault; Pascale Ghillani; Robert P Myers; Jean Marc Leger; Jérôme Servan; Jean-Charles Piette
Journal:  Arthritis Rheum       Date:  2002-12

Review 2.  Management of hepatitis C virus-related mixed cryoglobulinemia.

Authors:  Francesco Iannuzzella; Augusto Vaglio; Giovanni Garini
Journal:  Am J Med       Date:  2010-05       Impact factor: 4.965

3.  Cryoglobulinemia in Japanese patients with chronic hepatitis C virus infection: host genetic and virological study.

Authors:  A Nagasaka; T Takahashi; T Sasaki; K Takimoto; K Miyashita; M Nakamura; O Wakahama; S Nishikawa; A Higuchi
Journal:  J Med Virol       Date:  2001-09       Impact factor: 2.327

4.  Using standardized serum creatinine values in the modification of diet in renal disease study equation for estimating glomerular filtration rate.

Authors:  Andrew S Levey; Josef Coresh; Tom Greene; Lesley A Stevens; Yaping Lucy Zhang; Stephen Hendriksen; John W Kusek; Frederick Van Lente
Journal:  Ann Intern Med       Date:  2006-08-15       Impact factor: 25.391

5.  Telaprevir for previously untreated chronic hepatitis C virus infection.

Authors:  Ira M Jacobson; John G McHutchison; Geoffrey Dusheiko; Adrian M Di Bisceglie; K Rajender Reddy; Natalie H Bzowej; Patrick Marcellin; Andrew J Muir; Peter Ferenci; Robert Flisiak; Jacob George; Mario Rizzetto; Daniel Shouval; Ricard Sola; Ruben A Terg; Eric M Yoshida; Nathalie Adda; Leif Bengtsson; Abdul J Sankoh; Tara L Kieffer; Shelley George; Robert S Kauffman; Stefan Zeuzem
Journal:  N Engl J Med       Date:  2011-06-23       Impact factor: 91.245

6.  Antiviral therapy for hepatitis C virus--associated mixed cryoglobulinemia vasculitis: a long-term followup study.

Authors:  David Saadoun; Mathieu Resche-Rigon; Vincent Thibault; Jean-Charles Piette; Patrice Cacoub
Journal:  Arthritis Rheum       Date:  2006-11

7.  PEGylated interferon alfa-2b and ribavirin treatment in patients with hepatitis C virus-related systemic vasculitis.

Authors:  Patrice Cacoub; David Saadoun; Nicolas Limal; Damien Sene; Olivier Lidove; Jean-Charles Piette
Journal:  Arthritis Rheum       Date:  2005-03

Review 8.  Hepatitis C-associated mixed cryoglobulinaemia: a crossroad between autoimmunity and lymphoproliferation.

Authors:  D Saadoun; D A Landau; L H Calabrese; P P Cacoub
Journal:  Rheumatology (Oxford)       Date:  2007-06-12       Impact factor: 7.580

9.  Renal impairment is frequent in chronic hepatitis C patients under triple therapy with telaprevir or boceprevir.

Authors:  Stefan Mauss; Dietrich Hueppe; Ulrich Alshuth
Journal:  Hepatology       Date:  2013-11-11       Impact factor: 17.425

10.  Relapse of hepatitis C virus-associated mixed cryoglobulinemia vasculitis in patients with sustained viral response.

Authors:  Dan-Avi Landau; David Saadoun; Philippe Halfon; Michelle Martinot-Peignoux; Patrick Marcellin; Elena Fois; Patrice Cacoub
Journal:  Arthritis Rheum       Date:  2008-02
View more
  4 in total

1.  KDIGO 2018 Clinical Practice Guideline for the Prevention, Diagnosis, Evaluation, and Treatment of Hepatitis C in Chronic Kidney Disease.

Authors: 
Journal:  Kidney Int Suppl (2011)       Date:  2018-09-19

2.  Impact of DAA-Based Regimens on HCV-Related Extra-Hepatic Damage: A Narrative Review.

Authors:  Evangelista Sagnelli; Caterina Sagnelli; Antonio Russo; Mariantonietta Pisaturo; Clarissa Camaioni; Roberta Astorri; Nicola Coppola
Journal:  Adv Exp Med Biol       Date:  2021       Impact factor: 2.622

3.  Reduced impact of renal failure on the outcome of patients with alcoholic liver disease undergoing liver transplantation.

Authors:  Jaeyoun Cheong; Joseph A Galanko; Sumant Arora; Joaquin Cabezas; Nambi J Ndugga; Michael R Lucey; Paul H Hayashi; Alfred Sidney Barritt; Ramon Bataller
Journal:  Liver Int       Date:  2016-07-04       Impact factor: 5.828

Review 4.  Treatment of Hepatitis C in Patients Undergoing Immunosuppressive Drug Therapy.

Authors:  Kohtaro Ooka; Joseph K Lim
Journal:  J Clin Transl Hepatol       Date:  2016-08-10
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.